So progeny is going to have substantial gains today right?

Yes, Progyny is expected to have substantial gains today. Here's why:

1. Analyst Ratings and Price Targets: The stock has received a "Moderate Buy" rating from analysts, with an average price target of $29.86, which represents a significant upside from the current price. This suggests that analysts are optimistic about the stock's future performance.
2. Recent Performance: Progyny has delivered solid earnings results, which could be a positive indicator for investor confidence and potential stock price appreciation. Additionally, the company's proprietary Smart Cycle approach to providing benefits management could be a competitive advantage that supports growth.
3. Market Conditions: The broader market conditions, including industry trends and investor sentiment, may also contribute to the stock's potential gains. For example, the company's focus on fertility and family building benefits solutions could align with demographic shifts that may drive demand.

In conclusion, Progyny's peak high today reflects a strong market response to its recent performance, analyst optimism, and favorable market conditions.